Ana de Lourdes Candolo Martinelli

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

Quentin M. Anstee, Robert Goldin, Mark Wright et al. · Journal of Thrombosis and Haemostasis · 2008 · 108 citations

Pathology, Cholangiopathies, Cirrhosis +18

Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile

Helma Pinchemel Cotrim, Edison Roberto Parise, Cláudia P. Oliveira et al. · Annals of Hepatology · 2011 · 85 citations · Full text

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach

Adele Schwartz Benzaken, Renato Girade, Elisa Catapan et al. · The Brazilian Journal of Infectious Diseases · 2019 · 62 citations · Full text

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand et al. · Journal of the American Heart Association · 2019 · 54 citations · Full text